Page last updated: 2024-12-06

tri-n-butylborane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Tri-n-butylborane (TBB) is a colorless, flammable liquid that is highly reactive. It is commonly used as a polymerization initiator and a reducing agent. It is synthesized by the reaction of tri-n-butylaluminum with boron trifluoride. TBB can be used to initiate the polymerization of various monomers, including olefins, styrenes, and acrylates. It can also be used to reduce a variety of functional groups, such as ketones, aldehydes, and esters. TBB is studied for its potential applications in organic synthesis, polymer chemistry, and material science.'

Cross-References

ID SourceID
PubMed CID31216
MeSH IDM0054311

Synonyms (20)

Synonym
einecs 204-554-6
ccris 4133
tributylborine
tri-n-butyl borane
brn 1738107
tri-n-butylborane
borane, tributyl-
tributylborane
tributylboron
A804918
tributyl-borane
122-56-5
AKOS015918440
FT-0631702
DTXSID9059543
(n-c4h9)3b
tributyl borane
tri-n-butylboron
mfcd00009423
BCP18543
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (116)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (12.93)18.7374
1990's41 (35.34)18.2507
2000's35 (30.17)29.6817
2010's21 (18.10)24.3611
2020's4 (3.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.11 (24.57)
Research Supply Index4.82 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (15.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.65%)5.53%
Reviews2 (1.65%)6.00%
Case Studies4 (3.31%)4.05%
Observational0 (0.00%)0.25%
Other113 (93.39%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]